Cancer-associated oxidoreductase ERO1-α drives the production of tumor-promoting myeloid-derived suppressor cells via oxidative protein folding

Journal of Immunology

Volumn 194, Issue 4, 2015, Pages 2004-2010

  Tanaka, Tsutomu ^a,b   Kajiwara, Toshimitsu ^a   Torigoe, Toshihiko ^a   Okamoto, Yoshiharu ^c   Sato, Noriyuki ^a   Tamura, Yasuaki ^d  

^a SAPPORO MEDICAL UNIVERSITY   (Japan)

^b YAMAGUCHI UNIVERSITY   (Japan)

^c TOTTORI UNIVERSITY   (Japan)

^d HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; GRANULOCYTE COLONY STIMULATING FACTOR; PROTEIN ERO1 ALPHA; TUMOR PROTEIN; UNCLASSIFIED DRUG; ERO1L PROTEIN, HUMAN; ERO1L PROTEIN, MOUSE; GLYCOPROTEIN; MEMBRANE PROTEIN; OXIDOREDUCTASE;

AEROBIC METABOLISM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER CELL LINE; CANCER GROWTH; CELL INFILTRATION; CONTROLLED STUDY; DISULFIDE BOND; FEMALE; GRANULOCYTE; HUMAN; HUMAN CELL; MOUSE; MYELOID DERIVED SUPPRESSOR CELL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN INDUCTION; SUPPRESSOR CELL; TUMOR PROMOTION; TUMOR VOLUME; UPREGULATION; WILD TYPE; ANIMAL; BAGG ALBINO MOUSE; BONE MARROW CELL; BREAST TUMOR; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYMOLOGY; FLOW CYTOMETRY; GENE SILENCING; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; NEUTROPHIL; NUDE MOUSE; OXIDATION REDUCTION REACTION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE; TUMOR MICROENVIRONMENT; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL LINE, TUMOR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GENE KNOCKDOWN TECHNIQUES; GLYCOPROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, NUDE; MYELOID CELLS; NEUTROPHILS; OXIDATION-REDUCTION; OXIDOREDUCTASES; PROTEIN FOLDING; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR MICROENVIRONMENT;

EID: 84922572914     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1402538     Document Type: Article

References (26)

1. Gabrilovich, D. L, and S. Nagaraj. 2009. Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 9: 162-174.
2. Nagaraj, S., A. G. Schrum, H. I. Cho, E. Celis, and D. I. Gabrilovich. 2010. Mechanism of T cell tolerance induced by myeloid-derived suppressor cells. J. Immunol. 184: 3106-3116.
3. Khaled, Y. S., B. J. Ammori, and E. Elkord. 2014. Increased levels of granulocytic myeloid-derived suppressor cells in peripheral blood and tumour tissue of pancreatic cancer patients. J. Immunol. Res. 2014: 879897.
4. Meyer, C, A. Sevko, M. Ramacher, A. V. Bazhin, C. S. Falk, W. Osen, I. Borrello, M. Kato, D. Schadendorf, M. Baniyash, and V. Umansky. 2011. Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma model. Proc. Natl. Acad. Sci. USA 108: 17111-17116.
5. Song, C, Y. Yuan, X. M. Wang, D. Li, G. M. Zhang, B. Huang, and Z. H. Feng. 2014. Passive transfer of tumour-derived MDSCs inhibits asthma-related airway inflammation. Scand. J. Immunol. 79: 98-104.
6. Kujawski, M., M. Kortylewski, H. Lee, A. Herrmann, H. Kay, and H. Yu. 2008. Stat3 mediates myeloid cell-dependent tumor angiogenesis in mice. J. Clin. Invest. 118: 3367-3377.
7. Oh, K., O. Y Lee, S. Y Shon, O. Nam, P. M. Ryu, M. W. Seo, and D. S. Lee. 2013. A mutual activation loop between breast cancer cells and myeloid-derived suppressor cells facilitates spontaneous metastasis through IL-6 trans-signaling in a murine model. Breast Cancer Res. 15: R79.
8. Markowitz, J., R. Wesolowski, T. Papenfuss, T. R. Brooks, and W. E. Carson, III. 2013. Myeloid-derived suppressor cells in breast cancer. Breast Cancer Res. Treat. 140: 13-21.
9. Asano, Y, T. Yokoyama, S. Shibata, S. Kobayashi, K. Shimoda, H. Nakashima, S. Okamura, and Y Niho. 1997. Effect of the chimeric soluble granulocyte colony-stimulating factor receptor on the proliferation of leukemic blast cells from patients with acute myeloblastic leukemia. Cancer Res. 57: 3395-3397.
10. Chakraborty, A., and S. Guha. 2007. Granulocyte colony-stimulating factor/ granulocyte colony-stimulating factor receptor biological axis promotes survival and growth of bladder cancer cells. Urology 69: 1210-1215.
11. Joshita, S., K. Nakazawa, Y Sugiyama, A. Kamijo, K. Matsubayashi, H. Miyabayashi, K. Furuta, K. Kitano, and S. Kawa. 2009. Granulocyte-colony stimulating factor-producing pancreatic adenosquamous carcinoma showing aggressive clinical course. Intern. Med. 48: 687-691.
12. Savarese, T. M., K. Mitchell, C. McQuain, C. L. Campbell, R. Guardiani, J. Wuu, C. Ollari, F. Reale, B. E. Nelson, A. Chen, and P. J. Quesenberry. 2001. Coexpression of granulocyte colony stimulating factor and its receptor in primary ovarian carcinomas. Cancer Lett. 162: 105-115.
13. Waight, J. D., Q. Hu, A. Miller, S. Liu, and S. I. Abrams. 2011. Tumor-derived G-CSF facilitates neoplastic growth through a granulocytic myeloid-derived suppressor cell-dependent mechanism. PLoS ONE 6: e27690.
14. Abrams, S. I., and J. D. Waight. 2012. Identification of a G-CSF-Granulocytic MDSC axis that promotes tumor progression. Oncolmmunology 1: 550-551.
15. Frand, A. R., and C. A. Kaiser. 1999. Erolp oxidizes protein disulfide isomerase in a pathway for disulfide bond formation in the endoplasmic reticulum. Mol. Cell 4: 469-477.
16. Appenzell er-Herzog, C, J. Riemer, B. Christensen, E. S. S Orensen, and L. Ellgaard. 2008. A novel disulphide switch mechanism in Erolalpha balances ER oxidation in human cells. EMBO J. 27: 2977-2987.
17. Appenzell er-Herzog, C, J. Riemer, E. Zito, K. T. Chin, D. Ron, M. Spiess, and L. Ellgaard. 2010. Disulphide production by Ero1α-PDI relay is rapid and effectively regulated. EMBO J. 29: 3318-3329.
18. Araki, K., and K. Nagata. 2011. Functional in vitro analysis of the ERO1 protein and protein-disulfide isomerase pathway. J. Biol. Chem. 286: 32705-32712.
19. Kutomi, G., Y Tamura, T. Tanaka, T. Kajiwara, K. Kukita, T. Ohmura, H. Shima, T. Takamaru, F Satomi, Y Suzuki, et al. 2013. Human endoplasmic reticulum oxidoreductin 1-α is a novel predictor for poor prognosis of breast cancer. Cancer Sci. 104: 1091-1096.
20. Acharyya, S., T. Oskarsson, S. Vanharanta, S. Malladi, J. Kim, P. G. Morris, K Manova-Todorova, M. Leversha, N. Hogg, V. E. Seshan, et al. 2012. A CXCL1 paracrine network links cancer chemoresistance and metastasis. Cell 150: 165-178.
21. Katoh, H., D. Wang, T. Daikoku, H. Sun, S. K. Dey, and R. N. Dubois. 2013. CXCR2-expressing myeloid-derived suppressor cells are essential to promote colitis-associated tumorigenesis. Cancer Cell 24: 631-644.
22. Mo, J., A. A. Tymiak, and G. Chen. 2013. Characterization of disulfide linkages in recombinant human granulocyte-colony stimulating factor. Rapid Commun. Mass Spectrom. 27: 940-946.
23. Cabibbo, A., M. Pagani, M. Fabbri, M. Rocchi, M. R. Farmery, N. J. Bulleid, and R. Sitia. 2000. ERO1-L, a human protein that favors disulfide bond formation in the endoplasmic reticulum. J. Biol. Chem. 275: 4827-4833.
24. Gess, B., K H. Hofbauer, R. H. Wenger, C. Lohaus, H. E. Meyer, and A. Kurtz. 2003. The cellular oxygen tension regulates expression of the endoplasmic ox-idoreductase ERO1-Lalpha. Eur. J. Biochem. 270: 2228-2235.
25. May, D., A. Itin, O. Gal, H. Kalinski, E. Feinstein, and E. Keshet. 2005. Erol-L alpha plays a key role in a HIF-1-mediated pathway to improve disulfide bond formation and VEGF secretion under hypoxia: implication for cancer. Oncogene 24: 1011-1020.
26. Araki, K., and K. Inaba. 2012. Structure, mechanism, and evolution of Erol family enzymes. Antioxid. Redox Signal. 16: 790-799.